In 2024, SIA "FuturaPharm" had revenue of 46.1 thousand EUR and loss of 58 thousand EUR. The company has 3 employees.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 46,1k € | 0 € | 0 € |
Profit | -58k € -867.1% | -6k € -5956.6% | -99 € -4.2% |
Assets | 40,6k € +232.3% | 12,2k € +6038.2% | 199 € -33.4% |
Liabilities | 58k € +208.1% | 18,8k € +2212.8% | 814 € -0.1% |
Equity | -17,4k € -163.2% | -6,6k € -975.0% | -615 € -19.2% |
Employees | 3 +200.0% | 1 | 0 |
Overall rating | B68/100 |
Financial health | 15/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 75/100 |
| Overall risk | Medium |
No risk flags | |
No tax debts | |
Negative profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board member | Together with at least | ||||
| Board member | Together with at least |
| Name | Changed |
|---|---|
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
| Sabiedrība ar ierobežotu atbildību "BALTIC BIOSCIENCE" | 30 May 2023 |
SIA "FuturaPharm" is located at Rīga, Kalnciema iela 27 - 1, LV-1046.
In 2024, SIA "FuturaPharm" had revenue of 46 116 EUR and loss of 57 988 EUR. View full financial report →
In 2024, SIA "FuturaPharm" had an average of 3 employees. View tax history →
No, SIA "FuturaPharm" does not have an active VAT number and is not registered as a VAT payer.
In 2024, the average gross salary at SIA "FuturaPharm" was approximately 918,32 € per month (net ~ 742,36 €). This is an approximate calculation. View salary details →
SIA "FuturaPharm" was founded on September 19, 2014. The company has been operating for 12 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 12 years | 91 - 95 | 56% | |
Net revenue | 46 116,00 € | 89 - 93 | 52% | |
Profit | -57 988,00 € | 189 - 193 | 9% | |
Equity | -17 399,00 € | - | 10% | |
Assets | 40 596,00 € | 123 - 127 | 38% | |
Liquidity | 1.36 | - | 50% | |
Profitability | -125.7% | - | 10% | |
Registered capital | 50 000,00 € | - | 90% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Birth date | Shares | Ownership rights | |
|---|---|---|---|---|
| SIA "Klīnika Piramīda 3" | - | 27 500 | 55.00% | |
| Elīna Vaivode | 7500 | 15.00% | ||
| Līna Zvirbule | 7500 | 15.00% | ||
| SIA "Alfamed" | - | 3750 | 7.50% | |
| Anna Verhoustinska | 3750 | 7.50% | ||